APA (7th ed.) Citation

Hanusch, C. A., Schneeweiss, A., Loibl, S., Untch, M., Paepke, S., Kümmel, S., . . . Minckwitz, G. v. (2015). Dual blockade with AFatinib and trastuzumab as NEoadjuvant treatment for patients with locally advanced or operable breast cancer receiving taxane-anthracycline containing chemotherapy-DAFNE (GBG-70). Clinical cancer research, 21(13), . https://doi.org/10.1158/1078-0432.CCR-14-2774

Chicago Style (17th ed.) Citation

Hanusch, Claus Alexander, et al. "Dual Blockade with AFatinib and Trastuzumab as NEoadjuvant Treatment for Patients with Locally Advanced or Operable Breast Cancer Receiving Taxane-anthracycline Containing Chemotherapy-DAFNE (GBG-70)." Clinical Cancer Research 21, no. 13 (2015). https://doi.org/10.1158/1078-0432.CCR-14-2774.

MLA (9th ed.) Citation

Hanusch, Claus Alexander, et al. "Dual Blockade with AFatinib and Trastuzumab as NEoadjuvant Treatment for Patients with Locally Advanced or Operable Breast Cancer Receiving Taxane-anthracycline Containing Chemotherapy-DAFNE (GBG-70)." Clinical Cancer Research, vol. 21, no. 13, 2015, https://doi.org/10.1158/1078-0432.CCR-14-2774.